The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
EANO guideline on the diagnosis and management of meningiomas
Open accessAbstract
Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials have been conducted to guide clinical decision making, resulting in variations of management approaches across countries and centers. However, recent advances in molecular genetics and clinical trial results help to refine the diagnostic and therapeutic approach to meningioma. Accordingly, the European Association of Neuro-Oncology (EANO) updated its recommendations for the diagnosis and treatment of meningiomas. A provisional diagnosis of meningioma is typically made by neuroimaging, mostly magnetic resonance imaging. Such provisional diagnoses may be made incidentally. Accordingly, a significant proportion of meningiomas, notably in patients that are asymptomatic or elderly or both, may be managed by a watch-and-scan strategy. A surgical intervention with tissue, commonly with the goal of gross total resection, is required for the definitive diagnosis according to the WHO classification. A role for molecular profiling including gene panel sequencing and genomic methylation profiling is emerging. A gross total surgical resection including the involved dura is often curative. Inoperable or recurrent tumors requiring treatment can be treated with radiosurgery, if the size or the vicinity of critical structures allows that, or with fractionated radiotherapy (RT). Treatment concepts combining surgery and radiosurgery or fractionated RT are increasingly used, although there remain controversies regard timing, type, and dosing of the various RT approaches. Radionuclide therapy targeting somatostatin receptors is an experimental approach, as are all approaches of systemic pharmacotherapy. The best albeit modest results with pharmacotherapy have been obtained with bevacizumab or multikinase inhibitors targeting vascular endothelial growth factor receptor, but no standard of care systemic treatment has been yet defined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz150 · Cited by 2,585
THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENT
Simpson, D. (1957) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.20.1.22 · Cited by 2,414
Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO
Clark, V. E., Erson-Omay, E. Z., Serin, A., Yin, J., Cotney, J., Özduman, K., Avşar, T., Li, J., Murray, P. B., Henegariu, O., et al. (2013) · Science · doi:10.1126/science.1233009 · Cited by 912
EANO guidelines for the diagnosis and treatment of meningiomas
Goldbrunner, R., Minniti, G., Preusser, M., Jenkinson, M. D., Sallabanda, K., Houdart, E., von Deimling, A., Stavrinou, P., Lefranc, F., Lund-Johansen, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30321-7 · Cited by 854
Self-citationSahm, F., Schrimpf, D., Stichel, D., Jones, D. T. W., Hielscher, T., Schefzyk, S., Okonechnikov, K., Koelsche, C., Reuss, D. E., Capper, D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30155-9 · Cited by 852
Self-citationGenomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Brastianos, P. K., Horowitz, P. M., Santagata, S., Jones, R. T., McKenna, A., Getz, G., Ligon, K. L., Palescandolo, E., Van Hummelen, P., Ducar, M. D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2526 · Cited by 651
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Sahm, F., Schrimpf, D., Olar, A., Koelsche, C., Reuss, D., Bissel, J., Kratz, A., Capper, D., Schefzyk, S., Hielscher, T., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv377 · Cited by 406
Self-citationBrainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
Preoperative and postoperative cognitive functioning in patients with frontal meningiomas
Tucha, O., Smely, C., Preier, M., Becker, G., Paul, G. M., & Lange, K. W. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.1.0021 · Cited by 295
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Kaley, T. J., Wen, P., Schiff, D., Ligon, K., Haidar, S., Karimi, S., Lassman, A. B., Nolan, C. P., DeAngelis, L. M., Gavrilovic, I., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou148 · Cited by 294
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
Abedalthagafi, M., Bi, W. L., Aizer, A. A., Merrill, P. H., Brewster, R., Agarwalla, P. K., Listewnik, M. L., Dias-Santagata, D., Thorner, A. R., Van Hummelen, P., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov316 · Cited by 293
Leone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 280
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539
Rogers, L., Zhang, P., Vogelbaum, M. A., Perry, A., Ashby, L. S., Modi, J. M., Alleman, A. M., Galvin, J., Brachman, D., Jenrette, J. M., et al. (2018) · Journal of Neurosurgery · doi:10.3171/2016.11.jns161170 · Cited by 277
Kaley, T., Barani, I., Chamberlain, M., McDermott, M., Panageas, K., Raizer, J., Rogers, L., Schiff, D., Vogelbaum, M., Weber, D., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not330 · Cited by 270
Self-citationNassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., Saarela, O., Poisson, L., Gepfner-Tuma, I., Schittenhelm, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz061 · Cited by 267
Self-citationLoss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Smith, M. J., O'Sullivan, J., Bhaskar, S. S., Hadfield, K. D., Poke, G., Caird, J., Sharif, S., Eccles, D., Fitzpatrick, D., Rawluk, D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2552 · Cited by 261
High Incidence of ActivatingTERTPromoter Mutations in Meningiomas Undergoing Malignant Progression
Goutagny, S., Nault, J. C., Mallet, M., Henin, D., Rossi, J. Z., & Kalamarides, M. (2014) · Brain Pathology · doi:10.1111/bpa.12110 · Cited by 249
Jenkinson, M. D., Javadpour, M., Haylock, B. J., Young, B., Gillard, H., Vinten, J., Bulbeck, H., Das, K., Farrell, M., Looby, S., et al. (2015) · Trials · doi:10.1186/s13063-015-1040-3 · Cited by 230
Self-citationCDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Sievers, P., Hielscher, T., Schrimpf, D., Stichel, D., Reuss, D. E., Berghoff, A. S., Neidert, M. C., Wirsching, H.-G., Mawrin, C., Ketter, R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02188-w · Cited by 227
Self-citationAdvances in meningioma genetics: novel therapeutic opportunities
Preusser, M., Brastianos, P. K., & Mawrin, C. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.168 · Cited by 220
Self-citationHigh-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539
Rogers, C. L., Won, M., Vogelbaum, M. A., Perry, A., Ashby, L. S., Modi, J. M., Alleman, A. M., Galvin, J., Fogh, S. E., Youssef, E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.11.028 · Cited by 200
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Lou, E., Sumrall, A. L., Turner, S., Peters, K. B., Desjardins, A., Vredenburgh, J. J., McLendon, R. E., Herndon, J. E., McSherry, F., Norfleet, J., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0861-0 · Cited by 196
Olar, A., Wani, K. M., Wilson, C. D., Zadeh, G., DeMonte, F., Jones, D. T. W., Pfister, S. M., Sulman, E. P., & Aldape, K. D. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1678-x · Cited by 192
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas
Shankar, G. M., Abedalthagafi, M., Vaubel, R. A., Merrill, P. H., Nayyar, N., Gill, C. M., Brewster, R., Bi, W. L., Agarwalla, P. K., Thorner, A. R., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now235 · Cited by 184
Weber, D. C., Ares, C., Villa, S., Peerdeman, S. M., Renard, L., Baumert, B. G., Lucas, A., Veninga, T., Pica, A., Jefferies, S., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.06.018 · Cited by 181
Self-citationAssociations of meningioma molecular subgroup and tumor recurrence
Youngblood, M. W., Miyagishima, D. F., Jin, L., Gupte, T., Li, C., Duran, D., Montejo, J. D., Zhao, A., Sheth, A., Tyrtova, E., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noaa226 · Cited by 166
Ji, Y., Rankin, C., Grunberg, S., Sherrod, A. E., Ahmadi, J., Townsend, J. J., Feun, L. G., Fredericks, R. K., Russell, C. A., Kabbinavar, F. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6490 · Cited by 164
Vasudevan, H. N., Braunstein, S. E., Phillips, J. J., Pekmezci, M., Tomlin, B., Wu, A., Reis, G. F., Magill, S. T., Zhang, J., Feng, F. Y.-C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.013 · Cited by 154
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma
Han, S. J., Reis, G. F., Kohanbash, G., Shrivastav, S., Magill, S. T., Molinaro, A. M., McDermott, M. W., Theodosopoulos, P. V., Aghi, M. K., Berger, M. S., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2256-0 · Cited by 134
Seystahl, K., Stoecklein, V. M., Schüller, U., Rushing, E. J., Nicolas, G., Schäfer, N., Ilhan, H., Pangalu, A., Weller, M., Tonn, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now060 · Cited by 133
Self-citationSimultaneous precise editing of multiple genes in human cells
Riesenberg, S., Chintalapati, M., Macak, D., Kanis, P., Maričić, T., & Pääbo, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz669 · Cited by 133
Mirian, C., Duun‐Henriksen, A. K., Juratli, T. A., Sahm, F., Spiegl‐Kreinecker, S., Peyre, M., Biczok, A., Tonn, J., Goutagny, S., Bertero, L., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322257 · Cited by 132
Self-citationCurrent status of PET imaging in neuro-oncology
Galldiks, N., Lohmann, P., Albert, N. L., Tonn, J. C., & Langen, K. (2019) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdz010 · Cited by 129
van Nieuwenhuizen, D., Klein, M., Stalpers, L. J. A., Leenstra, S., Heimans, J. J., & Reijneveld, J. C. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9366-7 · Cited by 126
Self-citationLate neurocognitive sequelae in patients with WHO grade I meningioma
Dijkstra, M., van Nieuwenhuizen, D., Stalpers, L. J. A., Wumkes, M. L., Waagemans, M., Vandertop, W. P., Heimans, J. J., Leenstra, S., Dirven, C. M. F., Reijneveld, J. C., et al. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138925 · Cited by 122
Self-citationWilliams, E. A., Santagata, S., Wakimoto, H., Shankar, G. M., Barker, F. G., Sharaf, R., Reddy, A. K., Spear, P., Alexander, B. M., Ross, J. S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01040-2 · Cited by 121
Muskens, I. S., Briceno, V., Ouwehand, T. L., Castlen, J. P., Gormley, W. B., Aglio, L. S., Najafabadi, A. H. Z., van Furth, W. R., Smith, T. R., Mekary, R. A., et al. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-017-3390-y · Cited by 117
Establishment of a benign meningioma cell line by hTERT-mediated immortalization
Püttmann, S., Senner, V., Braune, S. A., Hillmann, B., Exeler, R., Rickert, C. H., & Paulus, W. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700307 · Cited by 116
Haberg, A. K., Hammer, T. A., Kvistad, K. A., Rydland, J., Müller, T. B., Eikenes, L., Gårseth, M., & Stovner, L. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151080 · Cited by 110
Cognitive functioning in meningioma patients: a systematic review
Meskal, I., Gehring, K., Rutten, G.-J. M., & Sitskoorn, M. M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2115-z · Cited by 108
Gallium‐68 DOTATATE PET in the Evaluation of Intracranial Meningiomas
Ivanidze, J., Roytman, M., Lin, E., Magge, R., Pisapia, D. J., Liechty, B., Karakatsanis, N. A., Ramakrishna, R. R., Knisely, J. P. S., Schwartz, T. H., et al. (2019) · Journal of Neuroimaging · doi:10.1111/jon.12632 · Cited by 105
Characterization of a Newly Established Malignant Meningioma Cell Line of the Human Brain: IOMM-Lee
Lee, W. (1990) · Neurosurgery · doi:10.1227/00006123-199009000-00008 · Cited by 97
Nassiri, F., Price, B., Shehab, A., Au, K., Cusimano, M. D., Jenkinson, M. D., Jungk, C., Mansouri, A., Santarius, T., Suppiah, S., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy152 · Cited by 97
Self-citationIslim, A. I., Kolamunnage‐Dona, R., Mohan, M., Moon, R. D. C., Crofton, A., Haylock, B. J., Rathi, N., Brodbelt, A. R., Mills, S. J., & Jenkinson, M. D. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz160 · Cited by 88
Self-citationLee, E. J., Kim, J. H., Park, E. S., Kim, Y., Lee, J. K., Hong, S. H., Cho, Y. H., & Kim, C. J. (2017) · Journal of neurosurgery · doi:10.3171/2016.9.jns161669 · Cited by 87
Meskal, I., Gehring, K., van der Linden, S. D., Rutten, G.-J. M., & Sitskoorn, M. M. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1679-8 · Cited by 85
Brain invasion in otherwise benign meningiomas does not predict tumor recurrence
Baumgarten, P., Gessler, F. A., Schittenhelm, J., Skardelly, M., Tews, D. S., Senft, C., Dunst, M., Imoehl, L., Plate, K. H., Wagner, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1598-1 · Cited by 85
Preusser, M., Silvani, A., Rhun, É. L., Soffietti, R., Lombardi, G., Sepúlveda-Sánchez, J. M., Brandal, P., Brazil, L., Bonneville-Levard, A., Lorgis, V., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab243 · Cited by 84
Self-citationCognitive function of patients with brain tumor in pre- and postoperative stage
Yoshii, Y., Tominaga, D., Sugimoto, K., et al. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2007.07.064 · Cited by 82
YAP1-fusions in pediatric NF2-wildtype meningioma
Sievers, P., Chiang, J., Schrimpf, D., Stichel, D., Paramasivam, N., Sill, M., Gayden, T., Casalini, B., Reuß, D., Dalton, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02095-9 · Cited by 79
Self-citationBrenner, A. V., Sugiyama, H., Preston, D. L., Sakata, R., French, B. C., Sadakane, A., Cahoon, E. K., Utada, M., Mabuchi, K., & Ozasa, K. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00599-y · Cited by 78
Steinvorth, S., Welzel, G., Fuß, M., Debus, J., Wildermuth, S., Wannenmacher, M. F., & Wenz, F. K. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00204-4 · Cited by 73
Rijnen, S. J. M., Meskal, I., Bakker, M., Baene, W. D., Rutten, G.-J. M., Gehring, K., & Sitskoorn, M. M. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz039 · Cited by 72
Cognitive and emotional problems in patients after cerebral meningioma surgery
van der Vossen, S., Schepers, V. P. M., van der Sprenkel, J. W. B., Visser‐Meily, J. M. A., & Post, M. W. M. (2014) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1795 · Cited by 70
Genomic profile of human meningioma cell lines
Mei, Y., Bi, W. L., Greenwald, N. F., Agar, N. Y. R., Beroukhim, R., Dunn, G. P., & Dunn, I. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178322 · Cited by 67
van Nieuwenhuizen, D., Ambachtsheer, N., Heimans, J. J., Reijneveld, J. C., Peerdeman, S. M., & Klein, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1132-4 · Cited by 65
Self-citationEffects of surgery on cognitive functioning of elderly patients with intracranial meningioma
O. Tucha, C. S. (2001) · British Journal of Neurosurgery · doi:10.1080/02688690151127608 · Cited by 61
Quality of life after surgery for intracranial meningioma
Benz, L., Wrensch, M., Schildkraut, J. M., Bondy, M. L., Warren, J. L., Wiemels, J. L., & Claus, E. B. (2017) · Cancer · doi:10.1002/cncr.30975 · Cited by 58
Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer
Shah, N. R., Tancioni, I., Ward, K. K., Lawson, C., Chen, X. L., Jean, C., Sulzmaier, F. J., Uryu, S. A., Miller, N. L. G., Connolly, D. C., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.044 · Cited by 57
Proctor, D. T., Patel, Z., Lama, S., Resch, L., van Marle, G., & Sutherland, G. R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1512943 · Cited by 55
Hartrampf, P. E., Hänscheid, H., Kertels, O., Schirbel, A., Kreissl, M. C., Flentje, M. P., Sweeney, R. A., Buck, A. K., Polat, B., & Lapa, C. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.03.002 · Cited by 52
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features
Williams, E. A., Wakimoto, H., Shankar, G. M., Barker, F. G., Brastianos, P. K., Santagata, S., Sokol, E. S., Pavlick, D. C., Shah, N., Reddy, A. K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02161-7 · Cited by 52
Moreau, J. T., Hankinson, T. C., Baillet, S., & Dudley, R. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0219-5 · Cited by 46
Hendrix, P., Hans, E., Griessenauer, C. J., Simgen, A., Oertel, J., & Karbach, J. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.10.095 · Cited by 45
von Spreckelsen, N., Waldt, N., Poetschke, R., Kesseler, C., Dohmen, H., Jiao, H., Németh, A., Schob, S., Scherlach, C., Sandalcioglu, I. E., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00912-x · Cited by 43
Self-citationReview of controversies in management of non-benign meningioma
Paldor, I., Awad, M., Sufaro, Y. Z., Kaye, A. H., & Shoshan, Y. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.03.014 · Cited by 42
Pre-operative and post-operative cognitive deficits in patients with supratentorial meningiomas
Bommakanti, K., Somayajula, S., Alladi, S., et al. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.02.033 · Cited by 40
Alfredo, C., Carolin, S., Acker, G., Kluge, A. K., Pontoriero, A., Cacciola, A., Pergolizzi, S., Germanò, A., Badakhshi, H., Kufeld, M., et al. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1397-7 · Cited by 40
Najafabadi, A. H. Z., Peeters, M. C. M., Lobatto, D. J., Broekman, M. L. D., Smith, T. R., Biermasz, N. R., Peerdeman, S. M., Peul, W. C., TAPHOORN, M. J. B., van Furth, W. R., et al. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-017-3332-8 · Cited by 34
Machine Learning in Meningioma MRI: Past to Present. A Narrative Review
Neromyliotis, E., Κalamatianos, T., Paschalis, A., Komaitis, S., Fountas, K. N., Kapsalaki, E. Z., Stranjalis, G., & Tsougos, I. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27378 · Cited by 34
van Nieuwenhuizen, D., Slot, K.-A. M., Klein, M., Verbaan, D., Aliaga, E. S., Heimans, J. J., Vandertop, W. P., Peerdeman, S. M., & Reijneveld, J. C. (2019) · Acta Neurochirurgica · doi:10.1007/s00701-019-03819-2 · Cited by 31
Self-citationAntitumor activity of gemcitabine against high-grade meningiomain vitroandin vivo
Takeda, H., Okada, M., Kuramoto, K., Suzuki, S., Sakaki, H., Sanomachi, T., Seino, S., Yoshioka, T., Hirano, H., Arita, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18827 · Cited by 26
Barresi, V., Lionti, S., Rocca, L. L., Caliri, S. L., & Caffo, M. (2018) · Neuropathology · doi:10.1111/neup.12524 · Cited by 11
Jenkinson, M. D., Weber, D. C., Haylock, B. J., Sherratt, F. C., Young, B., Weller, M., Bulbeck, H., Culeddu, G., Hughes, D. A., Brain, A., et al. (2018) · Journal of neurosurgery · doi:10.3171/2018.6.jns181418 · Cited by 3
Self-citation
Cited by
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Torp, S. H., Solheim, O., & Skjulsvik, A. J. (2022) · Acta Neurochirurgica · doi:10.1007/s00701-022-05301-y · Cited by 303
Metadata
- Authors
- Goldbrunner, R., Stavrinou, P., Jenkinson, M. D., Sahm, F., Mawrin, C., Weber, D. C., Preusser, M., Minniti, G., Lund-Johansen, M., Lefranc, F., Houdart, E., Sallabanda, K., Le Rhun, E., Nieuwenhuizen, D., Tabatabai, G., Soffietti, R., & Weller, M.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-28
- Volume
- 23
- Issue
- 11
- Pages
- 1821-1834
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W3174532670
- Cited by
- 742
- References
- 76
- FWCI
- 66.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.